Cornerstone Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-310
| Closed | -$221K | – | 614 |
|
|
2024
Q4 | $221K | Buy |
310
+10
| +3% | +$7.12K | 0.01% | 539 |
|
|
2024
Q3 | $315K | Sell |
300
-17
| -5% | -$17.9K | 0.02% | 449 |
|
|
2024
Q2 | $333K | Buy |
317
+17
| +6% | +$17.9K | 0.03% | 416 |
|
|
2024
Q1 | $289K | Hold |
300
| – | – | 0.02% | 433 |
|
|
2023
Q4 | $263K | Sell |
300
-3
| -1% | -$2.64K | 0.02% | 436 |
|
|
2023
Q3 | $249K | Buy |
303
+3
| +1% | +$2.47K | 0.02% | 456 |
|
|
2023
Q2 | $216K | Sell |
300
-90
| -23% | -$64.7K | 0.02% | 474 |
|
|
2023
Q1 | $320K | Buy |
+390
| New | +$320K | 0.03% | 363 |
|
|
2022
Q3 | $322K | Hold |
468
| – | – | 0.04% | 334 |
|
|
2022
Q2 | $277K | Buy |
468
+78
| +20% | +$46.2K | 0.03% | 365 |
|
|
2022
Q1 | $272K | Sell |
390
-14
| -3% | -$9.76K | 0.03% | 383 |
|
|
2021
Q4 | $254K | Buy |
+404
| New | +$254K | 0.02% | 435 |
|
|
2018
Q4 | – | Sell |
-43,199
| Closed | -$92K | – | 954 |
|
|
2018
Q3 | $92K | Sell |
43,199
-60,738
| -58% | -$129K | ﹤0.01% | 1270 |
|
|
2018
Q2 | $296K | Buy |
+103,937
| New | +$296K | ﹤0.01% | 1205 |
|